Italy is rapidly building a national ecosystem for advanced therapies, positioning itself at the forefront of gene therapy and RNA-based medicines. Backed by more than €320 million in funding from the EU’s recovery plan, the country has created a coordinated research network designed to accelerate innovation and move discoveries from the lab to clinical use.
At the center of this effort is a structured system connecting universities, hospitals, and private partners. The network includes 10 specialized hubs, 44 research institutions, and 58 affiliated organizations working together across the country. This model allows Italy not only to participate in global biomedical innovation but increasingly to generate its own technologies and therapies.
